Mode
Text Size
Log in / Sign up

Machine learning algorithm predicts skip metastasis in papillary thyroid cancer in retrospective cohort

Machine learning algorithm predicts skip metastasis in papillary thyroid cancer in retrospective coh…
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider the machine learning model for skip metastasis in PTC as preliminary, requiring external validation.

A retrospective cohort study at a single hospital department developed and validated a machine learning algorithm to predict skip metastasis (lateral lymph node metastasis without central lymph node involvement) in papillary thyroid cancer. The study included 361 patients who underwent thyroidectomy with central and lateral lymph node dissections. The incidence of skip metastasis was 13.02% (47 of 361 patients). The study identified pertinent risk factors for skip metastasis and tested six machine learning models, finding the random forest model performed best based on accuracy, sensitivity, specificity, positive predictive value, negative predictive value, F1 score, kappa statistics, area under the curve, and decision curve analysis showing clinical advantage.

Safety and tolerability data were not reported in this analysis. The study's key limitations include its retrospective design, single-center setting, and reliance on internal validation only. No external validation of the predictive model was performed.

The authors suggest the model offers promise for routine clinical use by precisely identifying skip metastases using an uncomplicated approach. However, given the observational nature of the evidence and the significant limitations, this represents preliminary research. The findings show association, not causation, between identified risk factors and skip metastasis. Clinical application would require confirmation through prospective, multi-center studies with external validation.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedMar 2026
View Original Abstract ↓
BackgroundSkip metastasis from papillary thyroid cancer (PTC) is often unpredictable and characterized by lateral lymph node metastasis without central lymph node metastasis. Our objective was to provide a predictive model for skip metastases to cervical lymph nodes based on clinical and demographic data using machine learning.Materials and methodsFrom January 2016 to December 2021, patients who underwent thyroidectomy, central lymph node dissection, and lateral lymph node dissection at the Department of Thyroid Surgery at our hospital, had their clinical and pathological data analyzed retrospectively. Following the identification of five critical characteristics, six machine learning models were developed. Accuracy, sensitivity, specificity, positive predictive value, negative predictive value, F1 score, kappa statistics, and area under the curve were measured in the performance evaluation process, and decision curve analysis was used to determine the clinical advantage. Next, universality was assessed through internal validation. R and Python software was used for all statistical analyses and model construction.ResultsThe incidence of skip lymph node metastases was 13.02% (47/361). Pertinent elements encompassed the number of nodes removed as a result of central lymph node dissection, the existence or non-existence of Hashimoto thyroiditis, the largest tumour size, its bilateral nature, and its multifocal nature. By outperforming alternative models, the random forest model demonstrated excellent performance on the internal validation cohort.ConclusionThis study focused on identifying the risk factors associated with skip metastasis, with the aim of developing an efficient predictive model for this condition using readily available clinical variables. This model can precisely identify skip metastases in PTC using an uncomplicated approach, offering promise for routine clinical use.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.